Gradient Denervation Technologies

Provider of an endovascular, catheter-based technology to treat pulmonary hypertension

placeParis, Ile De France, France calendar_todayFounded 2020 groups4 employees language gradientdenervation.com

Social engagement

Social engagement: 2.4K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Asabys Partners, Sofinnova Partners.

Investor typeCountShare
Venture capital360%
Accelerator & incubator240%

Recent activity

27 Feb 2026
Event
Transcatheter Heart Therapies THT 2026 meeting
23 Oct 2025
Recognition
Coming soon